{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:15:23Z","timestamp":1786119323273,"version":"build-2736575974"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1097\/mbc.0b013e3283177b03","type":"journal-article","created":{"date-parts":[[2008,12,22]],"date-time":"2008-12-22T03:13:41Z","timestamp":1229915621000},"page":"81-83","source":"Crossref","is-referenced-by-count":12,"title":["Resolution of platelet function defects with imatinib therapy in a patient with chronic myeloid leukaemia in chronic phase"],"prefix":"10.1097","volume":"20","author":[{"given":"Ashley P","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Servadei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabel","family":"Tuckfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Friedhuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Grigg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210203","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2141.1997.d01-1982.x","article-title":"Clinical features at diagnosis in 430 patients with chronic myeloid leukaemia seen at a referral centre over a 16-year period","volume":"96","author":"Savage","year":"1997","journal-title":"Br J Haematol"},{"key":"R2-15-20210203","first-page":"251","article-title":"Bleeding and thrombosis in chronic myeloproliferative disorders: relation of platelet disorders to clinical aspects of the disease","volume":"19","author":"Wehmeier","year":"1989","journal-title":"Haemostasis"},{"key":"R3-15-20210203","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMoa022457","article-title":"Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia","volume":"348","author":"O'Brien","year":"2003","journal-title":"N Engl J Med"},{"key":"R4-15-20210203","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF01707281","article-title":"Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders. A retrospective analysis of 260 patients","volume":"63","author":"Wehmeier","year":"1991","journal-title":"Ann Hematol"},{"key":"R5-15-20210203","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1600-0609.1988.tb00835.x","article-title":"Platelet function in myeloproliferative disorders: characterization and sequential studies show multiple platelet abnormalities, and change with time","volume":"40","author":"Baker","year":"1988","journal-title":"Eur J Haematol"},{"key":"R6-15-20210203","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1046\/j.1365-2141.1998.01115.x","article-title":"BCR-ABL oncoprotein is expressed by platelets from CML patients and associated with a special pattern of CrkL phosphorylation","volume":"103","author":"ten Bosch","year":"1998","journal-title":"Br J Haematol"},{"key":"R7-15-20210203","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1046\/j.1365-2141.2001.02624.x","article-title":"Platelet activation via the collagen receptor GPVI is not altered in platelets from chronic myeloid leukaemia patients despite the presence of the constitutively phosphorylated adapter protein CrkL","volume":"112","author":"Best","year":"2001","journal-title":"Br J Haematol"},{"key":"R8-15-20210203","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1600-0609.1981.tb01391.x","article-title":"Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function tests","volume":"25","author":"Boneu","year":"1980","journal-title":"Scand J Haematol"},{"key":"R9-15-20210203","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1600-0609.1981.tb01405.x","article-title":"Platelets in myeloproliferative disorders. II. Serotonin uptake and storage: correlations with mepacrine labelled dense bodies and with platelet density","volume":"25","author":"Caranobe","year":"1980","journal-title":"Scand J Haematol"},{"key":"R10-15-20210203","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/ajh.2830220408","article-title":"Acquired von Willebrand disease and storage pool disease in chronic myelocytic leukemia","volume":"22","author":"Mohri","year":"1986","journal-title":"Am J Hematol"},{"issue":"1 Suppl 1","key":"R11-15-20210203","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1053\/j.seminhematol.2005.11.009","article-title":"Glanzmann's thrombasthenia treatment: a prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agents","volume":"43","author":"Poon","year":"2006","journal-title":"Semin Hematol"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MBC.0b013e3283177b03","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:58:25Z","timestamp":1786039105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-200901000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e3283177b03","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}